Ikarian Capital, LLC Sangamo Therapeutics, Inc Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,860,179 shares of SGMO stock, worth $837,080. This represents 0.17% of its overall portfolio holdings.
Number of Shares
1,860,179
Previous 1,860,179
-0.0%
Holding current value
$837,080
Previous $1.9 Million
35.32%
% of portfolio
0.17%
Previous 0.31%
Shares
1 transactions
Others Institutions Holding SGMO
# of Institutions
133Shares Held
51.4MCall Options Held
1.94MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.22 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.09 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.12 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.03 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $70.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...